Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myelomonocytic, Chronic 6 Advanced Solid Tumor 6 Triple Negative Breast Neoplasms 4 Neoplasms 4 Breast Neoplasms 4 Advanced Solid Tumour 4 Advanced Solid Tumors 4 Solid Tumor 3 Myeloproliferative Disorders 3 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Monocytic, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡